Lindbrook Capital’s Biohaven BHVN Stock Holding History

Lindbrook Capital’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$15.3K	Sell	636 -66	-9%	-$2.33K	﹤0.01%	1469
2024 Q4	$26.2K	Sell	702 -10	-1%	-$467	﹤0.01%	1129
2024 Q3	$35.6K	Buy	712 +17	+2%	+$661	﹤0.01%	978
2024 Q2	$24.1K	Buy	695 +71	+11%	+$2.81K	﹤0.01%	1133
2024 Q1	$34.1K	Hold	624	–	–	﹤0.01%	946
2023 Q4	$26.7K	Sell	624 -1	-0.2%	-$31	﹤0.01%	1030
2023 Q3	$16.3K	Sell	625 -8	-1%	-$166	﹤0.01%	1166
2023 Q2	$15.1K	Hold	633	–	–	﹤0.01%	1234
2023 Q1	$8.65K	Sell	633 -15	-2%	-$239	﹤0.01%	1535
2022 Q4	$8.99K	Buy	+648	New	+$9.15K	﹤0.01%	1491

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Lindbrook Capital's BHVN Position: Q1 2025 in Review

Lindbrook Capital reduced its Biohaven (BHVN) stake by 9.4% in Q1 2025, selling an estimated $2.33K and leaving 636 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1469.

Lindbrook Capital first reported a position in BHVN in Q4 2022 and has held it in 10 quarters since. The position peaked at $35.6K in Q3 2024. 266 funds tracked by Wall St. Rank hold BHVN as of Q1 2025.

Lindbrook Capital held 636 shares of Biohaven worth $15.3K as of Q1 2025.
Lindbrook Capital sold 66 Biohaven shares in Q1 2025, an estimated $2.33K.
Biohaven made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1469 holding.
Lindbrook Capital first reported a position in Biohaven in Q4 2022 and has held it in 10 quarters since.
Lindbrook Capital's Biohaven position peaked at $35.6K in Q3 2024.
266 funds tracked by Wall St. Rank held Biohaven as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.